Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Heart Attack & Stroke Prevention Center (HASPC) is a specialized medical facility dedicated to the early detection and prevention of cardiovascular events. It serves as the clinical headquarters for the BaleDoneen Method, a peer-reviewed, evidence-based protocol focused on identifying and treating subclinical arterial disease and systemic inflammation. The center utilizes advanced diagnostic tools, including genetic testing, inflammatory biomarker analysis, and carotid intima-media thickness (cIMT) imaging, to create personalized prevention plans. Beyond direct patient care, HASPC provides education and certification for healthcare professionals worldwide to implement these preventive strategies in their own practices.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Heart Attack & Stroke Prevention Center.